Drug discovery has long been criticized for its slow, costly, and failure-prone nature. Traditional approaches, particularly ...

As artificial intelligence (AI) reshapes industries, its transformative potential comes with a complex web of regulatory ...

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

The visit—Huang’s third to China this year—coincided with a series of significant developments: regulatory approval for ...

By 2023, the tone had shifted. Venture capital cooled. According to CB Insights, funding for AI drug discovery start-ups ...

Jessica Copeland and Marc Krawiec explain that despite early provisions in the One Big Beautiful Bill Act to block state ...

As AI, model-based systems engineering and digital thread strategies evolve, they're transforming how organizations define ...

Regulatory activity covering the development and use of AI continues apace, and as part of this trend, there is growing pressure to ensure that AI systems are not only effective but also observable, ...

Google, Meta, and CoreWeave lead an expected $90 billion wave of AI and energy investments in Pennsylvania, marking a shift ...

The failure to enact a proposed 10-year moratorium on state AI regulations brings meaningful clarity for employers, according ...

U.S. President Donald Trump is slated to deliver a message outlining his vision for America's role in the development of ...

As technology continues to reshape financial services, regulators and policy setters are embarking on a range of ...